April 14, local time, the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization held an emergency meeting on the suspension of the Johnson and Johnson vaccine. The committee’s panel of experts said there was not enough data to support a final decision and that more time was needed to evaluate the data, and that the Johnson vaccine would be temporarily deactivated before the next meeting.
The committee’s panel of experts said they wanted to know data on people who developed blood clots after being vaccinated against Johnson and Johnson. The expert group stressed the need for sufficient data to understand the link between blood clots and vaccines. It is reported that the committee will confirm the next meeting and discussion of data date before the 16th.